Protara Therapeutics (TARA) Treasury Shares (2022 - 2025)
Protara Therapeutics (TARA) recorded quarterly Treasury Shares of $571145.0 in Q4 2025, up 2.86% quarter-over-quarter from $555245.0 in Q3 2025, and up 93.01% on a YoY basis from $295914.0 in Q4 2024.
Protara Therapeutics (TARA) Treasury Shares (2022 - 2025) Analysis & Trends
Protara Therapeutics' Treasury Shares history runs 4 years deep, the most recent figure standing at $571145.0 for Q4 2025.
- In Q4 2025, Treasury Shares rose 93.01% year-over-year to $571145.0; the TTM figure through Dec 2025 stood at $571145.0 (up 93.01% YoY), while the FY2025 annual figure was $571145.0, up 93.01% from the prior year.
- Treasury Shares was $571145.0 for Q4 2025 at Protara Therapeutics, up from $555245.0 in the prior quarter.
- In the past five years, Treasury Shares ranged from a high of $571145.0 in Q4 2025 to a low of $196838.0 in Q4 2022.
- Historically, Treasury Shares has averaged $368608.2 across 4 years, with a median of $319404.5 in 2024.
- Biggest YoY gain for Treasury Shares was 93.01% in 2025; the steepest drop was 12.16% in 2025.
- A 4-year view of Treasury Shares shows it stood at $196838.0 in 2022, then increased by 20.24% to $236679.0 in 2023, then climbed by 25.03% to $295914.0 in 2024, then soared by 93.01% to $571145.0 in 2025.
- The last three Treasury Shares figures came in at $571145.0 (Q4 2025), $555245.0 (Q3 2025), and $510945.0 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | - |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | - |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | 1.48 Mn |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | 700,000.00 |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | - |
| 10 | Protara Therapeutics | 216.35 Mn | 216.35 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 571,145.00 |
| Dec 31, 2025 | 571,145.00 |
| Sep 30, 2025 | 555,245.00 |
| Sep 30, 2025 | 555,245.00 |
| Jun 30, 2025 | 510,945.00 |
| Jun 30, 2025 | 510,945.00 |
| Mar 31, 2025 | 384,593.00 |
| Mar 31, 2025 | 384,593.00 |
| Dec 31, 2024 | 295,914.00 |
| Dec 31, 2024 | 295,914.00 |
| Sep 30, 2024 | 295,914.00 |
| Sep 30, 2024 | 295,914.00 |
| Jun 30, 2024 | 295,914.00 |
| Jun 30, 2024 | 295,914.00 |
| Mar 31, 2024 | 342,895.00 |
| Mar 31, 2024 | 342,895.00 |
| Dec 31, 2023 | 236,679.00 |
| Dec 31, 2023 | 236,679.00 |
| Dec 31, 2022 | 196,838.00 |
| Dec 31, 2022 | 196,838.00 |